13.85
0.04 (0.29%)
0.04 (0.29%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 5,752,153 |
|
|||||
| News | - | ||||||
| Day High | 14.06 | Low High |
|||||
| Day Low | 13.25 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Revance Therapeutics Inc | RVNC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.04 | 0.29% | 13.85 | 19:50:34 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.05 | 13.25 | 14.06 | 13.85 | 13.81 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 39,386 | 5,752,153 | $ 13.81 | $ 79,412,688 | - | 13.01 - 33.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:53:34 | 39 | $ 13.87 | USD |
Period:
Draw Mode:
Revance Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 994.84M | 71.83M | 69.05M | $ 15.33M | $ - | -4.85 | -4.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -71.37k | 2.50% |
Revance Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RVNC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.30 | 27.44 | 13.01 | 16.82 | 5,474,104 | -13.45 | -49.27% |
| 1 Month | 27.77 | 30.00 | 13.01 | 18.72 | 1,662,191 | -13.92 | -50.13% |
| 3 Months | 29.58 | 30.57 | 13.01 | 21.54 | 821,879 | -15.73 | -53.18% |
| 6 Months | 27.05 | 33.83 | 13.01 | 24.52 | 600,939 | -13.20 | -48.8% |
| 1 Year | 25.77 | 33.83 | 13.01 | 25.51 | 540,080 | -11.92 | -46.26% |
| 3 Years | 24.16 | 34.62 | 9.88 | 21.35 | 537,481 | -10.31 | -42.67% |
| 5 Years | 14.70 | 37.45 | 9.88 | 22.87 | 428,387 | -0.85 | -5.78% |
Revance Therapeutics Description
| Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in research and development of aesthetic and therapeutic products. |
